Habershon, S. O. Acute poisoning by phosphorus; jaundice; death on the fifth day. Fatty degeneration of the liver, kidneys, gastric follicles, pancreas, heart, &c. Med. Chir. Trans. 50, 87–98 (1867).
Petrov, M. S. & Taylor, R. Intra-pancreatic fat deposition: bringing hidden fat to the fore. Nat. Rev. Gastroenterol. Hepatol. 19, 153–168 (2022).
Souza, M. et al. Prevalence, clinical characteristics, and outcomes of fatty pancreas disease: an updated systematic review and meta-analysis. Eur. J. Gastroenterol. Hepatol. 37, 137–146 (2025).
Yamazaki, H. & Petrov, M. S. Systematic mapping of worldwide research on intra-pancreatic fat deposition. Expert Rev. Gastroenterol. Hepatol. 19, 697–700 (2025).
Gatidis, S. et al. Better together: data harmonization and cross-study analysis of abdominal MRI data from UK Biobank and the German National Cohort. Invest. Radiol. 58, 346–354 (2023).
Gattrell, W. T. et al. ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi. PLoS Med. 21, e1004326 (2024).
Rubino, F. et al. Joint international consensus statement for ending stigma of obesity. Nat. Med. 26, 485–497 (2020).
Oxford Centre for Evidence-Based Medicine. OECBM levels of evidence. https://www.cebm.ox.ac.uk/resources/levels-of-evidence (2011).
Yasgur B. S. A common pancreatic condition that few have heard of. Medscape https://www.medscape.com/viewarticle/common-pancreatic-condition-few-have-heard-2025a10005wa?form=fpf (2025).
Ko, J. & Petrov, M. S. Intra-pancreatic fat deposition and pancreatitis: insights from the COSMOS program. Diabetes Metab. Syndr. Obes. 18, 1489–1500 (2025).
Scully, J. L. What is a disease? EMBO Rep. 5, 650–653 (2004).
Zhan, H. X., Zhang, T. P., Liu, B. N., Liao, Q. & Zhao, Y. P. A systematic review of pancreatic lipoma: how come there are so few cases? Pancreas 39, 257–260 (2010).
Askan, G. & Basturk, O. Mesenchymal tumors involving the pancreas: a clinicopathologic analysis and review of the literature. Turk. Patoloji Derg. 38, 46–53 (2022).
Fukukura, Y. et al. Computed tomography and magnetic resonance imaging features of lipid-rich neuroendocrine tumors of the pancreas. World J. Gastroenterol. 21, 10008–10017 (2015).
Klimov, S. et al. Predicting metastasis risk in pancreatic neuroendocrine tumors using deep learning image analysis. Front. Oncol. 10, 593211 (2021).
Fujita, Y. et al. Hyperplasia of fat-containing cells with mature adipocyte marker is associated with pancreatic fat enlargement. Pancreas 54, e221–e226 (2025).
Noronha, M., Salgadinho, A., Ferreira De Almeida, M. J., Dreiling, D. A. & Bordalo, O. Alcohol and the pancreas. I. Clinical associations and histopathology of minimal pancreatic inflammation. Am. J. Gastroenterol. 76, 114–119 (1981).
Horii, T. et al. Lipid droplet accumulation in β cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and β cell dysfunction involving decreased insulin granules. Front. Endocrinol. 13, 996716 (2022).
Zhang, N. et al. Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes. Diabetologia 68, 1242–1260 (2025).
Tong, X. et al. Lipid droplet accumulation in human pancreatic islets is dependent on both donor age and health. Diabetes 69, 342–354 (2020).
Bonal, C. et al. Pancreatic inactivation of c-Myc decreases acinar mass and transdifferentiates acinar cells into adipocytes in mice. Gastroenterology 136, 309–319 (2009).
Martinelli, P. et al. Gata6 is required for complete acinar differentiation and maintenance of the exocrine pancreas in adult mice. Gut 62, 1481–1488 (2013).
Augereau, C. et al. Chronic pancreatitis and lipomatosis are associated with defective function of ciliary genes in pancreatic ductal cells. Hum. Mol. Genet. 25, 5017–5026 (2016).
Lough, A. K. & Garton, G. A. The lipids of human pancreas with special reference to the presence of fatty acid methyl esters. Lipids 3, 321–323 (1968).
Durand, S., Estival, A., Vieu, C., Clemente, F. & Douste-Blazy, L. Lipid content of human and rat pancreas. Pancreas 2, 326–332 (1987).
Sattar, N., Forrest, E. & Preiss, D. Non-alcoholic fatty liver disease. BMJ 349, g4596 (2014).
Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005).
Stuart, C. E. et al. Relationship of pancreas volume to tobacco smoking and alcohol consumption following pancreatitis. Pancreatology 20, 60–67 (2020).
Korc, M., Jeon, C. Y., Edderkaoui, M., Pandol, S. J. & Petrov, M. S. Tobacco and alcohol as risk factors for pancreatic cancer. Best Pract. Res. Clin. Gastroenterol. 31, 529–536 (2017).
Oquendo, M. B. et al. Pancreatic fat cells of humans with type 2 diabetes display reduced adipogenic and lipolytic activity. Am. J. Physiol. Cell Physiol.320, C1000–C1012 (2021).
Cai, W. et al. Extracellular volume-based scoring system for tracking tumor progression in pancreatic cancer patients receiving intraoperative radiotherapy. Insights Imaging 15, 116 (2024).
Mirilas, P. & Skandalakis, J. E. Surgical anatomy of the retroperitoneal spaces part II: the architecture of the retroperitoneal space. Am. Surg. 76, 33–42 (2010).
Sackett, S. D. et al. Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas. Sci. Rep. 8, 10452 (2018).
Schmitz-Moormann, P., Pittner, P. & Heinze, W. Lipomatosis of the pancreas: a morphometrical investigation. Pathol. Res. Pract. 173, 45–53 (1981).
Olsen, T. S. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol. Microbiol. Scand. A 86, 367–373 (1978).
Tremmel, D. M. et al. Hypertension, but not body mass index, is predictive of increased pancreatic lipid content and islet dysfunction. Am. J. Transpl. 20, 1105–1115 (2020).
Cadenas-Sanchez, C. et al. Effects of a family-based lifestyle intervention plus supervised exercise training on abdominal fat depots in children with overweight or obesity: a secondary analysis of a nonrandomized clinical trial. JAMA Netw. Open 5, e2243864 (2022).
Saisho, Y. et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin. Anat. 20, 933–942 (2007).
Gyllenhammer, L. E., Alderete, T. L., Toledo-Corral, C. M., Weigensberg, M. & Goran, M. I. Saturation of subcutaneous adipose tissue expansion and accumulation of ectopic fat associated with metabolic dysfunction during late and post-pubertal growth. Int. J. Obes. 40, 601–606 (2016).
Raeder, H. et al. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes 56, 444–449 (2007).
Berrocal, T. et al. Shwachman-Diamond syndrome: clinical, radiological and sonographic aspects. Pediatr. Radiol. 25, 289–292 (1995).
Wicklow, B. A. et al. Pancreatic lipid content is not associated with beta cell dysfunction in youth-onset type 2 diabetes. Can. J. Diabetes 39, 398–404 (2015).
Stuart, C. E. et al. Implications of tobacco smoking and alcohol consumption on ectopic fat deposition in individuals after pancreatitis. Pancreas 49, 924–934 (2020).
Fridén, M., Kullberg, J., Ahlström, H., Lind, L. & Rosqvist, F. Intake of ultra-processed food and ectopic-, visceral- and other fat depots: a cross-sectional study. Front. Nutr. 9, 774718 (2022).
Mitsushio, K. et al. Relationships between intra-pancreatic fat deposition and lifestyle factors: a cross-sectional study. Front. Endocrinol. 14, 1219579 (2023).
Laposata, E. A. & Lange, L. G. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231, 497–499 (1986).
Machann, J. et al. Short-term variability of proton density fat fraction in pancreas and liver assessed by multiecho chemical-shift encoding-based MRI at 3 T. J. Magn. Reson. Imaging 56, 1018–1026 (2022).
Wong, V. W. et al. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. Am. J. Gastroenterol. 109, 589–597 (2014).
Heber, S. D. et al. Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease. PLoS ONE 12, e0177154 (2017).
Dong, X. et al. Associations of intrapancreatic fat deposition with incident diseases of the exocrine and endocrine pancreas: a UK Biobank prospective cohort study. Am. J. Gastroenterol. 119, 1158–1166 (2024).
Martin, S. et al. Estimating the effect of liver and pancreas volume and fat content on risk of diabetes: a Mendelian randomization study. Diabetes Care 45, 460–468 (2022).
Grune, E. et al. Subphenotypes of body composition and their association with cardiometabolic risk–magnetic resonance imaging in a population-based sample. Metabolism 164, 156130 (2025).
Jesuthasan, A. et al. Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss. Diabetologia 65, 226–233 (2022).
Skudder-Hill, L. et al. Fat distribution within the pancreas according to diabetes status and insulin traits. Diabetes 71, 1182–1192 (2022).
Uchida, T., Takada, T., Ammori, B. J., Suda, K. & Takahashi, T. Three-dimensional reconstruction of the ventral and dorsal pancreas: a new insight into anatomy and embryonic development. J. Hepatobiliary Pancreat. Surg. 6, 176–180 (1999).
Singh, R. G. et al. Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression. Metabolism 69, 1–13 (2017).
Wang, Y., Liu, Y. & Petrov, M. S. The effects of metabolic bariatric surgery on intra-pancreatic fat deposition and total pancreas volume: a systematic review and meta-analysis. Obes. Surg. 35, 1513–1524 (2025).
Wagner, R. et al. Pancreatic steatosis associates with impaired insulin secretion in genetically predisposed individuals. J. Clin. Endocrinol. Metab. 105, 3518–3525 (2020).
Kim, S. Y. et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology 271, 104–112 (2014).
Ko, J. et al. Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis. Diabetologia 66, 190–200 (2023).
Shamaitijiang, X. et al. Relationship of liver blood tests and T1 relaxation time with intra-pancreatic fat deposition. J. Clin. Exp. Hepatol. 14, 101343 (2024).
Skudder-Hill, L., Sequeira-Bisson, I. R., Ko, J., Poppitt, S. & Petrov, M. S. Relationship of fat deposition in the liver and pancreas with cholecystectomy. Obes. Facts 18, 468–480 (2025).
Singh, R. G. et al. Circulating levels of lipocalin-2 are associated with fatty pancreas but not fatty liver. Peptides 119, 170117 (2019).
Diamond, C. et al. Quantitative imaging reveals steatosis and fibroinflammation in multiple organs in people with type 2 diabetes: a real-world study. Diabetes 73, 1285–1299 (2024).
Koyuncu Sokmen, B., Sahin, T., Oral, A., Kocak, E. & Inan, N. The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates. Sci. Rep. 11, 4507 (2021).
Karaevren, T. T. et al. Fatty pancreas disease in newly diagnosed type 2 diabetes patients: a case–control study on relationships with glycemic control and exocrine function. Diabetol. Metab. Syndr. 17, 107 (2025).
Al-Mrabeh, A. et al. Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss. Cell Metab. 31, 233–249 (2020).
Skudder-Hill, L., Sequeira-Bisson, I. R., Ko, J., Poppitt, S. D. & Petrov, M. S. The moderating effect of cardiometabolic factors on the association between hepatic and intrapancreatic fat. Obesity 32, 2310–2320 (2024).
Petrov, M. S. Fatty change of the pancreas: the Pandora’s box of pancreatology. Lancet Gastroenterol. Hepatol. 8, 671–682 (2023).
Petrov, M. S. Fateful fat: intra-pancreatic lipids cause pancreatic cancer. Cell Rep. Med. 5, 101428 (2024).
Biczo, G. et al. Mitochondrial dysfunction, through impaired autophagy, leads to endoplasmic reticulum stress, deregulated lipid metabolism, and pancreatitis in animal models. Gastroenterology 154, 689–703 (2018).
Singh, R. G. et al. Associations between intra-pancreatic fat deposition and circulating levels of cytokines. Cytokine 120, 107–114 (2019).
Liu, Y. et al. Intra-pancreatic fat is associated with continuous glucose monitoring metrics. Diabetes Obes. Metab. 26, 2359–2367 (2024).
Ko, J., Skudder-Hill, L., Cho, J., Bharmal, S. H. & Petrov, M. S. Pancreatic enzymes and abdominal adipose tissue distribution in new-onset prediabetes/diabetes after acute pancreatitis. World J. Gastroenterol. 27, 3357–3371 (2021).
Gerst, F. et al. What role do fat cells play in pancreatic tissue? Mol. Metab. 25, 1–10 (2019).
Criddle, D. N. et al. Ethanol toxicity in pancreatic acinar cells: mediation by nonoxidative fatty acid metabolites. Proc. Natl Acad. Sci. USA 101, 10738–10743 (2004).
Luchini, C. et al. Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of interlobular/intralobular, intra-acinar, and intra-islet fat deposition. Lab. Invest. 105, 104214 (2025).
Cnop, M. et al. Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age. Am. J. Pathol. 156, 237–244 (2000).
Ko, J. et al. Associations between intra-pancreatic fat deposition, pancreas size, and pancreatic enzymes in health and after an attack of acute pancreatitis. Obes. Facts 15, 70–82 (2022).
Kimita, W., Skudder-Hill, L., Shamaitijiang, X., Priya, S. & Petrov, M. S. Associations of pancreas fat content and size with markers of iron metabolism. Obes. Res. Clin. Pract. 18, 56–63 (2024).
Bonilla, M. E. et al. Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment. JCI Insight 9, e180114 (2024).
Lilly, A. C., Astsaturov, I. & Golemis, E. A. Intrapancreatic fat, pancreatitis, and pancreatic cancer. Cell Mol. Life Sci. 80, 206 (2023).
Nadella, S. et al. Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G699–G712 (2018).
De Oliveira, C. et al. Pancreatic triglyceride lipase mediates lipotoxic systemic inflammation. J. Clin. Invest. 130, 1931–1947 (2020).
Masamune, A. et al. Effects of ethanol and its metabolites on human pancreatic stellate cells. Dig. Dis. Sci. 55, 204–211 (2010).
Otsuka, N., Shimizu, K., Taniai, M. & Tokushige, K. Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer. Front. Physiol. 14, 1243983 (2023).
Acharya, C. et al. Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology 145, 466–475 (2013).
Hart, N. J. et al. Cystic fibrosis–related diabetes is caused by islet loss and inflammation. JCI Insight 3, e98240 (2018).
Villaca, C. B. & Mastracci, T. L. Pancreatic crosstalk in the disease setting: understanding the impact of exocrine disease on endocrine function. Compr. Physiol. 14, 5371–5387 (2024).
Mareninova, O. A. et al. Dysregulation of mannose-6-phosphate-dependent cholesterol homeostasis in acinar cells mediates pancreatitis. J. Clin. Invest. 131, e146870 (2021).
Klein, L. et al. Explainable AI-based analysis of human pancreas sections identifies traits of type 2 diabetes. Nat. Commun. 17, 1558 (2026).
Carbone, C. et al. Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling. Int. J. Obes. 42, 334–343 (2018).
Kahn, D. E. & Bergman, B. C. Keeping it local in metabolic disease: adipose tissue paracrine signaling and insulin resistance. Diabetes 71, 599–609 (2022).
Ko, J. et al. Chronic pancreatitis is characterized by elevated circulating periostin levels related to intra-pancreatic fat deposition. J. Clin. Med. Res. 12, 568–578 (2020).
Yamazaki, H. et al. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: a prospective cohort and Mendelian randomization study. Cell Rep. Med. 5, 101391 (2024).
Koethe, J. R. et al. Associations between dietary carbohydrate intakes, fatty acid oxidation rates, and sites of ectopic fat deposition over two years in persons with treated HIV. J. Nutr. 155, 3057–3065 (2025).
Sul, H. H. et al. Burden of intrapancreatic fat deposition in type 2 diabetes and the role of obesity: a systematic review and meta-analysis. Curr. Obes. Rep. 15, 40 (2026).
Kim, M. K. et al. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes. Diabetes Res. Clin. Pract. 106, 590–596 (2014).
Staaf, J. et al. Pancreatic fat is associated with metabolic syndrome and visceral fat but not beta-cell function or body mass index in pediatric obesity. Pancreas 46, 358–365 (2017).
Yamazaki, H. et al. Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study. J. Gastroenterol. 55, 712–721 (2020).
Tang, Y. et al. CT quantitation and prediction of the risk of type 2 diabetes mellitus in non-obese patients with pancreatic fatty infiltration. Diabetes Metab. Syndr. Obes. 17, 2619–2625 (2024).
Godoy-Matos, A. F., Valerio, C. M., Moreira, R. O., Momesso, D. P. & Bittencourt, L. K. Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy. Diabetol. Metab. Syndr. 10, 71 (2018).
Wagner, R. et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat. Med. 27, 49–57 (2021).
Šebeková, K. et al. Lean insulin-resistant young adults display increased cardiometabolic risk: a retrospective cross-sectional study. Diabetes Res. Clin. Pract. 185, 109217 (2022).
Sorokin, E. P. et al. Genetic subtypes of type 2 diabetes are distinguished through the lens of abdominal MRI. Front. Genet. 16, 1605721 (2025).
Gu, X. et al. Mechanistic insights into how intrapancreatic fat deposition drives the development of acute pancreatitis. Int. J. Biol. Sci. 22, 4289–4302 (2026).
Ibrahim, R. M. et al. Fatty pancreas on EUS: risk factors, correlation with CT/MRI, and implications for pancreatic cancer screening. Endosc. Ultrasound 14, 13–19 (2025).
Keihanian, T. et al. Patterns of pancreatic fatty infiltration on endoscopic ultrasound: in-depth characterization. Eur. J. Gastroenterol. Hepatol. 38, 48–53 (2026).
Engjom, T. et al. Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI. PLoS ONE 13, e0201019 (2018).
Kiemen, A. L. et al. Magnetic resonance imaging-based assessment of pancreatic fat strongly correlates with histology-based assessment of pancreas composition. Pancreas 53, e180–e186 (2024).
Zhang, J., Liu, Y. & Petrov, M. S. Validation of magnetic resonance imaging for quantification of intrapancreatic fat deposition using phantom and histologic comparators: a systematic review and meta-analysis. Eur. Radiol. 36, 6546–6558 (2026).
Hernando, D. et al. Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom. Magn. Reson. Med. 77, 1516–1524 (2017).
Serai, S. D., Dillman, J. R. & Trout, A. T. Proton density fat fraction measurements at 1.5- and 3-T hepatic MR imaging: same-day agreement among readers and across two imager manufacturers. Radiology 284, 244–254 (2017).
Previtali, C. et al. Quantitative imaging predicts pancreatic fatty infiltration on routine CT examination. Diagn. Interv. Imaging 104, 359–367 (2023).
Tanabe, M. et al. Automated whole-volume measurement of CT fat fraction of the pancreas: correlation with Dixon MR imaging. Br. J. Radiol. 96, 20220937 (2023).
Yamazaki, H. et al. Fat distribution patterns and future type 2 diabetes. Diabetes 71, 1937–1945 (2022).
Ordulj, I. et al. Visceral and ectopic abdominal fat effect on the calcification of the abdominal aorta and its branches — an MSCT study. Life 14, 2 (2023).
Kumar, H., DeSouza, S. V. & Petrov, M. S. Automated pancreas segmentation from computed tomography and magnetic resonance images: a systematic review. Comput. Methods Prog. Biomed. 178, 319–328 (2019).
Rupp, S. et al. Acceleration of chemical shift encoding-based water-fat imaging for pancreatic proton density fat fraction mapping in a single breath-hold: data from the LION study. Eur. J. Radiol. 195, 112641 (2026).
Al-Mrabeh, A., Hollingsworth, K. G., Steven, S., Tiniakos, D. & Taylor, R. Quantification of intrapancreatic fat in type 2 diabetes by MRI. PLoS ONE 12, e0174660 (2017).
Idilman, I. S. et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom. Imaging 40, 1512–1519 (2015).
Nie, H., Liu, M., Duan, J. & Liu, H. Research on the relationship between ectopic fat and iron deposition in the liver and pancreas, with glucose metabolism in elderly obese patients. Diabetes Metab. Syndr. Obes. 18, 2331–2341 (2025).
Joshi, T., Virostko, J. & Petrov, M. S. Artificial intelligence-based models for quantification of intra-pancreatic fat deposition and their clinical relevance: a systematic review of imaging studies. Eur. Radiol. 36, 627–641 (2026).
Nalliah, S. et al. Deep-learning based automated pancreas segmentation on CT scans of chronic pancreatitis patients. Eur. J. Radiol. 189, 112175 (2025).
Kawamoto, S. et al. Deep neural network-based segmentation of normal and abnormal pancreas on abdominal CT: evaluation of global and local accuracies. Abdom. Radiol. 49, 501–511 (2024).
Schneider, E. et al. Long-term inter-platform reproducibility, bias, and linearity of commercial PDFF MRI methods for fat quantification: a multi-center, multi-vendor phantom study. Eur. Radiol. 31, 7566–7574 (2021).
Aliyari Ghasabeh, M. et al. Correlation between incidental fat deposition in the liver and pancreas in asymptomatic individuals. Abdom. Radiol. 45, 203–210 (2020).
Meloni, A. et al. Accurate estimate of pancreatic T2* values: how to deal with fat infiltration. Abdom. Imaging 40, 3129–3136 (2015).
Kühn, J. P. et al. Pancreatic steatosis demonstrated at MR imaging in the general population: clinical relevance. Radiology 276, 129–136 (2015).
Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline — third edition (CLSI document C28-A3) (CLSI, 2008).
Virostko, J. et al. Development of a standardized MRI protocol for pancreas assessment in humans. PLoS ONE 16, e0256029 (2021).
Yokoo, T. et al. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286, 486–498 (2018).
Petrov, M. S. Pancreatitis as a matter of fat: the causal role of high intrapancreatic fat deposition. Am. J. Gastroenterol. 119, 2372–2375 (2024).
Suda, K. Histopathological study on fat necrosis with comparison between agonal stage and acute pancreatitis. Rinsho Byori 39, 977–980 (1991).
Navina, S. et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci. Transl. Med. 3, 107ra110 (2011).
Al-Ani, Z., Ko, J. & Petrov, M. S. Intra-pancreatic fat deposition across the pancreatitis spectrum and the influence of gut hormones. Dig. Liver Dis. 55, 1081–1090 (2023).
Ko, J. et al. Intrapancreatic, liver, and skeletal muscle fat depositions in first attack of acute pancreatitis versus health. Am. J. Gastroenterol. 117, 1693–1701 (2022).
Yamazaki, H. et al. The causal effect of intrapancreatic fat deposition on acute and chronic pancreatitis: a Mendelian randomization study. Am. J. Gastroenterol. 118, 2540–2544 (2024).
Tirkes, T. et al. Multiparametric MRI scoring system of the pancreas for the diagnosis of chronic pancreatitis. J. Magn. Reson. Imaging 61, 2183–2194 (2025).
Swauger, S. E. et al. Association of pancreatic fat on imaging with pediatric metabolic co-morbidities. Pediatr. Radiol. 53, 2030–2039 (2023).
Almujarkesh, M. K. et al. Impact of pancreatic steatosis on risk of post-ERCP pancreatitis: systematic review and meta-analysis. Pancreatology 25, 1418–1425 (2025).
Sreedhar, U. L., DeSouza, S. V., Park, B. & Petrov, M. S. A systematic review of intra-pancreatic fat deposition and pancreatic carcinogenesis. J. Gastrointest. Surg. 24, 2560–2569 (2020).
Vlăduț, C. et al. High prevalence of pancreatic steatosis in pancreatic cancer patients: a meta-analysis and systematic review. Pancreatology 25, 98–107 (2025).
Oyama, H. et al. Relationship of intra-pancreatic fat deposition with pancreatic cancer differs according to carcinoma types. Gastroenterology 169, 718–721 (2025).
Rebours, V. et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (PanIN). Clin. Cancer Res. 21, 3522–3528 (2015).
Chatterjee, A. et al. Fatty pancreas disease and the risk of future diseases of the exocrine pancreas: a US matched cohort study. Am. J. Gastroenterol. 121, 1501–1508 (2026).
Zhou, L. et al. Impact of fatty pancreas on postoperative pancreatic fistulae: a meta-analysis. Front. Oncol. 11, 622282 (2021).
Chan, T. T. et al. Fatty pancreas is independently associated with subsequent diabetes mellitus development: a 10-year prospective cohort study. Clin. Gastroenterol. Hepatol. 20, 2014–2022 (2022).
Bi, Y., Lin, H. Y., Li, M. L., Zhou, J. & Sun, X. L. The association between pancreatic steatosis and metabolic syndrome: a 5-year follow-up study among a general Chinese population. Pancreas 51, 1000–1006 (2022).
Petrov, M. S. & Olesen, S. S. Metabolic sequelae: the pancreatitis zeitgeist of the 21st century. Gastroenterology 165, 1122–1135 (2023).
Petrov, M. S. Diagnosis of endocrine disease: post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur. J. Endocrinol. 184, R137–R149 (2021).
Petrov, M. S. & Basina, M. Diagnosis of endocrine disease: diagnosing and classifying diabetes in diseases of the exocrine pancreas. Eur. J. Endocrinol. 184, R151–R163 (2021).
Lee, N. et al. Characteristics and clinical course of diabetes of the exocrine pancreas: a nationwide population-based cohort study. Diabetes Care 45, 1141–1150 (2022).
Goodarzi, M. O. & Petrov, M. S. Diabetes of the exocrine pancreas: implications for pharmacological management. Drugs 83, 1077–1090 (2023).
Tirkes, T. et al. Association of pancreatic steatosis with chronic pancreatitis, obesity, and type 2 diabetes mellitus. Pancreas 48, 420–426 (2019).
Singh, R. G. et al. Intrapancreatic fat deposition and visceral fat volume are associated with the presence of diabetes after acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 316, G806–G815 (2019).
Ko, J., Skudder-Hill, L., Cho, J., Bharmal, S. H. & Petrov, M. S. The relationship between abdominal fat phenotypes and insulin resistance in non-obese individuals after acute pancreatitis. Nutrients 12, 2883 (2020).
Alexandre-Heymann, L. et al. CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes. Sci. Rep. 13, 10433 (2023).
Sequeiros, I. et al. MRI appearance of the pancreas in patients with cystic fibrosis: a comparison of pancreas volume in diabetic and non-diabetic patients. Br. J. Radiol. 83, 921–926 (2010).
Petrov, M. S. & Yadav, D. Global epidemiology and holistic prevention of pancreatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 175–184 (2019).
Lim, E. L. et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54, 2506–2514 (2011).
Steven, S. et al. Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 39, 808–815 (2016).
Al-Mrabeh, A. et al. 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 8, 939–948 (2020).
Rossi, A. et al. Effect of moderate weight loss on hepatic, pancreatic and visceral lipids in obese subjects. Nutr. Diabetes 2, e32 (2012).
Thomsen, M. N. et al. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 65, 506–517 (2022).
Tene, L. et al. The effect of long-term weight-loss intervention strategies on the dynamics of pancreatic-fat and morphology: an MRI RCT study. Clin. Nutr. ESPEN 24, 82–89 (2018).
Skytte, M. J. et al. A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. Diabetologia 62, 2066–2078 (2019).
Della Pepa, G. et al. An isoenergetic multifactorial diet reduces pancreatic fat and increases postprandial insulin response in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 45, 1935–1942 (2022).
Fotros, D. et al. Adherence to the dietary approaches to stop hypertension (DASH) and risk of pancreatic steatosis. J. Health Popul. Nutr. 43, 190 (2024).
Ko, J. et al. Intra-pancreatic fat deposition as a modifier of the relationship between habitual dietary fat intake and insulin resistance. Clin. Nutr. 40, 4730–4737 (2021).
Ko, J. et al. Dietary carbohydrate intake and insulin traits in individuals after acute pancreatitis: effect modification by intra-pancreatic fat deposition. Pancreatology 21, 353–362 (2021).
Li, M. et al. Aerobic training reduces pancreatic fat content and improves β-cell function: a randomized controlled trial using IDEAL-IQ magnetic resonance imaging. Diabetes Metab. Res. Rev. 38, e3516 (2022).
Heiskanen, M. A. et al. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial. Diabetologia 61, 1817–1828 (2018).
Langleite, T. M. et al. Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men. Arch. Physiol. Biochem. 122, 167–179 (2016).
Petrov, M. S. The pharmacological landscape for fatty change of the pancreas. Drugs 84, 375–384 (2024).
Agon, H. C., Shen, Y. & Petrov, M. S. Effects of glucose-lowering medications on intra-pancreatic fat deposition: a systematic review and meta-analysis of randomized controlled trials. Obes. Rev. 27, e70087 (2026).
Shi, M. et al. Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease. J. Diabetes Complications 37, 108610 (2023).
Smits, M. M. et al. Pancreatic effects of liraglutide or sitagliptin in overweight patients with type 2 diabetes: a 12-week randomized, placebo-controlled trial. Diabetes Care 40, 301–308 (2017).
Vanderheiden, A. et al. Mechanisms of action of liraglutide in patients with type 2 diabetes treated with high-dose insulin. J. Clin. Endocrinol. Metab. 101, 1798–1806 (2016).
Nieto, L. M. et al. Glucagon-like peptide-1 receptor agonists use does not increase the risk for acute pancreatitis and is associated with lower complications in patients with type 2 diabetes who develop acute pancreatitis: a multi-center analysis. Am. J. Gastroenterol. 121, 424–431 (2026).
Benny, O. et al. Dose-response analysis of tirzepatide and acute pancreatitis: an international systematic review and quantitative meta-analysis of randomised trials. Pancreatology 26, 552–565 (2026).
Becetti, I. et al. Changes in pancreatic steatosis by computed tomography 24 months after sleeve gastrectomy in youth with severe obesity. Surg. Obes. Relat. Dis. 21, 59–66 (2025).
Gaborit, B. et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int. J. Obes. 39, 480–487 (2015).
Yu, X., Huang, Y. H., Feng, Y. Z., Cheng, Z. Y. & Cai, X. R. Well-controlled versus poorly controlled diabetes in patients with obesity: differences in MRI-evaluated pancreatic fat content. Quant. Imaging Med. Surg. 13, 3496–3507 (2023).
Gao, X. et al. Impact of sleeve gastrectomy on ectopic fat deposition and skeletal muscle composition across glucose metabolic states. Obes. Surg. 35, 2689–2697 (2025).
Schifano, J. & Niederberger, M. How Delphi studies in the health sciences find consensus: a scoping review. Syst. Rev. 14, 14 (2025).
Byrne, M. et al. Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee. Blood Adv. 7, 4323–4326 (2023).
Zhang, Y., Liu, Y. & Petrov, M. S. Relationship of fat in the pancreas with cardiovascular disease: a systematic review and meta-analysis. Obes. Rev. 26, e13914 (2025).
Della Pepa, G., Salamone, D., Testa, R., Bozzetto, L. & Costabile, G. Intrapancreatic fat deposition and nutritional treatment: the role of various dietary approaches. Nutr. Rev. 82, 1820–1834 (2024).
Rodríguez, C. I. et al. Understanding the association of intrapancreatic fat deposition with adiposity and components of metabolic syndrome in children and adolescents: a systematic review and meta-analysis. EClinicalMedicine 83, 103205 (2025).
Leybourne, C. B., Liu, Y. & Petrov, M. S. Excessive intrapancreatic fat deposition and risk of pancreatic diseases: longitudinal cohort evidence from a systematic review with population-attributable fraction analysis. Am. J. Gastroenterol. 121, 1071–1081 (2026).
Vujasinovic, M. et al. International multidisciplinary consensus report on definitions, diagnostic criteria, and management of fatty pancreas: a joint statement endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG. U. Eur. Gastroenterol. J. 14, e70185 (2026).
Škrinjar, I., Vučić, K. & Puljak, L. Sample size and consensus methods used in Delphi studies are heterogeneous: meta-research study. J. Clin. Epidemiol. 195, 112262 (2026).
Diamond, I. R. et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J. Clin. Epidemiol. 67, 401–409 (2014).
Guillemin, F., Bombardier, C. & Beaton, D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J. Clin. Epidemiol. 46, 1417–1432 (1993).
Weichselbaum, A. & Stangl, E. Weitere histologische untersuchungen des pankreas bei diabetes mellitus. Wien. Klin. Wchnschr 15, 969–977 (1902).
Pressly, J. D. et al. Adaptive and maladaptive roles of lipid droplets in health and disease. Am. J. Physiol. Cell Physiol. 322, C468–C481 (2022).
Bosch, M., Sweet, M. J., Parton, R. G. & Pol, A. Lipid droplets and the host-pathogen dynamic: FATal attraction? J. Cell Biol. 220, e202104005 (2021).
Cho, J. & Petrov, M. S. Pancreatitis, pancreatic cancer, and their metabolic sequelae: projected burden to 2050. Clin. Transl. Gastroenterol. 11, e00251 (2020).